Thu.Jul 25, 2024

article thumbnail

STAT+: How UnitedHealth harnesses its physician empire to squeeze profits out of patients

STAT

UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed into a modern-day Standard Oil, exerting unmatched dominance over health care in the United States. It’s no secret that UnitedHealth is a colossus: It’s the country’s largest health insurer and the fourth-largest company of any type by revenue, just behind Apple.

article thumbnail

KCL study finds cell ageing could reveal early signs of neurodegenerative disease

Pharma Times

Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK

141
141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Watch: How insurers use doctors to profit off medical codes

STAT

Insurers like UnitedHealth are profiting off of the Medicare Advantage system, and it’s causing problems for both doctors and patients. Traditional Medicare is run by the federal government, while Medicare Advantage health insurance plans are operated by private companies like UnitedHealth. These privately run plans are still subsidized by government funds.

Hospitals 350
article thumbnail

MRC grants researcher £1.2m to further understand complex secretory processes

Pharma Times

The research will help to better understand how this pathway is coordinated in the cell

140
140
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: Adding psychotherapy to drug therapy works, but the FDA may not be able to handle it

STAT

Many people were stunned when an FDA advisory committee voted “no” on a new drug application for MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) earlier this summer. I was not among them. Several things were stacked against approval: The FDA greenlights only about 50 new drugs each year. Drug development is a high-risk business with an overall success rate between 10% and 20%.

article thumbnail

In biotech’s new market normal, here’s what’s catching this investor’s eye

PharmaVoice

A VC investor shares how the market is recovering, which kinds of companies he’s hunting for and where he’d love to see more innovation.

130
130

More Trending

article thumbnail

Pharmacy bodies join calls for improved contraception access

The Pharmacist

Everyone should have access to a full range of contraceptives in ‘the location of their choosing’, an open letter signed by the National Pharmacy Association (NPA) and the Royal Pharmaceutical Society (RPS) has urged. Dr Janet Barter, secretary of the Faculty of Sexual and Reproductive Health (FSRH), wrote to secretary of state Wes Streeting this […] The post Pharmacy bodies join calls for improved contraception access appeared first on The Pharmacist.

127
127
article thumbnail

STAT+: A preview of Neurocrine’s muscarinic drug readout

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Welcome back! I’ve been working from home almost this entire summer because of construction on the Red Line. I hate the MBTA. Boston readers know what I mean. This week: “Muscarinics” are hot and Neurocrine Biosciences is the next biotech with a big study readout.

article thumbnail

Sanofi’s immunology bet starts to pay off

BioPharma Dive

Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.

Immunity 115
article thumbnail

Opinion: Sponsored genetic testing programs are under fire, further complicating life for people with rare diseases

STAT

It takes years for most people with a rare disease to learn what is ailing them. Their symptoms may be crystal clear, but the cause isn’t. Efforts by the Department of Justice — an agency not known for its medical expertise — will make things even harder for the millions of Americans , half of them children, with one of these diseases.

292
292
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Can Pfizer, Sangamo energise haemophilia A gene therapy?

pharmaphorum

There has been a gene therapy on the market for people with the bleeding disorder haemophilia A since 2022, but take-up has been very slow. Pfizer and Sangamo are hoping for a faster trajectory with their experimental treatment.The partners' one-shot giroctocogene fitelparvovec therapy has cleared a phase 3 trial, showing it was better than regular prophylaxis injections with Factor VIII (FVIII) replacement therapies at reducing bleeding episodes, and could now be heading for regulatory review.

110
110
article thumbnail

Six questions about Medicare’s proposed plan to cover digital therapeutics

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Medicare regulators’ proposal to start paying for some digital therapeutics products created a wave of enthusiasm when it was released earlier this month.

280
280
article thumbnail

Patient engagement throughout the product lifecycle

pharmaphorum

Tune in to the Reverba podcast featuring CEO Cheryl Lubbert as she discusses patient engagement throughout the product lifecycle, sharing insights and strategies for success.

110
110
article thumbnail

STAT+: Roche CEO explains the company’s weight loss drug strategy in crowded market

STAT

LONDON — In the booming field of weight loss drugs, Roche has been riding high in recent months, with back-to-back positive studies of two experimental medicines that sent the company’s shares up — and those of its rivals down. But on Thursday, company executives faced an onslaught of questions from analysts during an earnings presentation about what came next for the company’s weight loss drugs and how they would stand apart in the wildly competitive field.

276
276
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Ageing Europe - It’s time we prioritised neurological conditions

pharmaphorum

Exploring the impact of ageing on Europe and the need to prioritise neurological conditions. Understand the role of neuroscience in addressing these issues.

109
109
article thumbnail

STAT+: Do medical errors creep up at hospitals when interns arrive? Yes, but the ‘July effect’ is minimal.

STAT

For Dr. Jeremy Faust, July 1 is like New Year’s Day. That’s when thousands of new medical school graduates enter teaching hospitals across the country and provide care to patients as doctors for the first time. “Everything is new and full of possibilities,” said Faust, an emergency physician at Brigham and Women’s Hospital.

Hospitals 276
article thumbnail

Ipsen builds again, licensing Day One glioma drug

pharmaphorum

Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceuticals.

105
105
article thumbnail

Listen: UnitedHealth’s doctor empire, an FDA departure, and Viking’s obesity moves

STAT

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHealth wields its unrivaled physician empire to boost its profits and expand its influence.

Hospitals 269
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

European big pharmas raise guidance on stronger sales

pharmaphorum

European pharma groups AstraZeneca, Sanofi, and Roche all raise their financial guidance for the year on stronger sales growth.

105
105
article thumbnail

A potential rival for Wegovy and Zepbound enters the fray

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Before we get to biotech, check out STAT’s deep dive into how UnitedHealth mobilizes a massive network of physicians and milked the health care system for profit.

article thumbnail

How to Develop a Competitive Edge in Generic Drug Development

Drug Patent Watch

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate the market.

article thumbnail

STAT+: Powerful Senate committee demands testimony from CEO of bankrupt Steward hospital chain

STAT

Federal lawmakers investigating the Steward Health Care bankruptcy moved on Thursday to compel testimony from chief executive Ralph de la Torre about his role in the hospital system’s financial collapse. The Senate Health, Education, Labor and Pensions Committee, which had not issued a subpoena to a potential witness since 1981, voted to require de la Torre to face questioning at a planned September 12 hearing.

Hospitals 258
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

NICE says Boehringer stroke drug 'could save millions'

pharmaphorum

NICE clears NHS use of Boehringer's clot-busting drug Metalyse for acute ischaemic stroke, saying it could 'save millions'

104
104
article thumbnail

STAT+: The state pharma’s targeting this election cycle

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Pharma locks in on North Carolina The pharmaceutical industry has lost some longtime allies in recent years. By the looks of it, executives and lobbyists are looking to North Carolina to make some new ones, according to federal campaign finance disclosures.

article thumbnail

Linus Health grows in dementia with Together acquisition

pharmaphorum

Digital dementia detection specialist Linus Health has expanded its patient care focus with the acquisition of Together Senior Health.

104
104
article thumbnail

A neurological disorder stole her voice. Jennifer Wexton takes it back on the House floor

STAT

When Jennifer Wexton rises Thursday to speak on the House floor, something she has done countless times before, the congresswoman will be using a voice she thought was gone forever. After a rare neurological disorder robbed her of her ability to speak clearly, Wexton has been given her voice back with the help of a powerful artificial intelligence program, allowing the Virginia Democrat to make a clone of her speaking voice using old recordings of speeches and appearances she made as a congressw

239
239
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharma Pulse 7/25/24: CrowdStrike Explains What Went Wrong Days After Global Tech Outage, The Future of Biosimilars & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

article thumbnail

NICE says Boehringer stroke drug 'could save millions'

pharmaphorum

NICE clears NHS use of Boehringer's clot-busting drug Metalyse for acute ischaemic stroke, saying it could 'save millions'

98
article thumbnail

How to Navigate the Generic Drug Market Post-COVID

Drug Patent Watch

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis.

98
article thumbnail

Suzanne LeBlang - passionate about patient care and the Focused Ultrasound Foundation

Outsourcing Pharma

When she was young, Suzanne used to love hearing her father, a cardiologist, talking to his colleagues on the phone about patients and the care they needed.

92
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.